No Name, Trump, 3M clash over order to produce more face masks for US

[Image]( EMAIL}/redirect Posted on Friday, April 3rd, 2020 By David Koenig And Zeke Miller, Associated Press President Donald Trump said Friday his administration will try to stop “profiteers” from exporting medical protective gear, shortly after picking a fight with manufacturing giant 3M, a major producer and exporter of face masks used to protect health care workers from the coronavirus. 3M argued that blocking exports will raise “significant humanitarian implications” abroad and lead other countries to retaliate by withholding much-needed medical supplies from the U.S. Nearly all of 3M’s exports of high-grade N95 masks go to Canada and Latin America, and Canadian officials led by Prime Minister Pierre Trudeau took the company’s side. They lobbied Trump administration officials not to cut off part of their supply. That was not enough to persuade Trump. Late Friday, the president announced that he will direct the Federal Emergency Management Agency to prevent the export of N95 masks, surgical gloves and other medical protective gear. He said exceptions might be made to help Italy and Spain, which have been hit hard by the coronavirus outbreak. “We are not happy with 3M,” Trump added during a White House briefing. The spat between the president and a leading American manufacturer started Thursday, after Trump used his authority under the 1950 Defense Production Act to direct the government to acquire the “appropriate” number of N95 respirators from Minnesota-based 3M and its subsidiaries. The N95 masks, also called respirators, provide more protection against the virus that causes COVID-19 than do ordinary surgical masks. Governors and hospital officials around the country have warned of a dire shortage of masks and other protective gear for health care workers treating infected patients. The president followed up his order with a barbed tweet Thursday night. “We hit 3M hard today after seeing what they were doing with their Masks. ‘P Act’ all the way. Big surprise to many in government as to what they were doing - will have a big price to pay!” Trump tweeted. EMAIL}/redirect EMAIL}/redirect The events leading to Trump's order against 3M began weeks ago. A White House official said when Vice President Mike Pence visited a 3M factory in Minnesota last month, he was told that 3M had 35 million N95 masks that were intended for commercial uses but could be used by health care workers. This week, after 3M received liability protection that it sought, the White House learned that not all of those masks were ready for the U.S. market, the official said. Jared Kushner, the president’s son-in-law, has been leading administration contacts with the company to learn where the masks went and why some were not available as promised. The situation led Trump to invoke the Defense Production Act, said the official, who spoke on condition of anonymity to discuss events that have not been made public. The company said, however, that it has been boosting production for the past two months and working with the Trump administration since last weekend to improve the supply of masks. The company said it has raised U.S. production of N95 masks from 22 million in January to 35 million in March, with the entire increase being distributed in the United States. 3M said 10 million N95 masks that it produced in China will be shipped to the U.S. The company has traditionally exported about 6 million masks a month to Canada and Latin America, where 3M is a primary supplier. 3M objected to stopping those exports. CEO Mike Roman said Trump’s insinuation that 3M was doing something wrong was "absurd.” EMAIL}/redirect EMAIL}/redirect “The idea that we are not doing everything we can to maximize deliveries of respirators in our home country — nothing is further from the truth,” he told CNBC. The company said stopping the export of respirators would cause other countries to stop shipments to the U.S., leading to fewer respirators being available. “That is the opposite of what we and the Administration, on behalf of the American people, both seek,” the company said in a statement. Canadian Prime Minister Justin Trudeau said essential health supplies and workers flow both ways across the border, and blocking exports of 3M masks would be a mistake. “I think of the thousands of nurses who cross the bridge in Windsor to work in the Detroit medical system every day,” Trudeau said. “These are things American rely on.” Doug Ford, premier of Ontario province, said he protested to U.S. Trade Representative Robert Lighthizer, expressing concern that Trump could create a shortage of masks for Canadian doctors and nurses. “The health and well-being of our frontline workers depend on these essential medical items and now more than ever our countries need to work together to combat COVID-19,” Ford tweeted. Others, however, said allowing the company to export masks could threaten safety of Americans. “The claim that it is humanitarian to ship masks that could have saved American lives to other countries will astonish and anger a lot of American customers of 3M,” said Erik Gordon, a business professor at the University of Michigan. The fight with 3M, while unusual, is not unprecedented. Just last week, Trump invoked the same 1950 law to force General Motors to build ventilators used to treat COVID-19 patients. Trump accused GM of not moving quickly enough to ramp up production, and of trying to overcharge the government. GM said it had been working on ventilators for weeks. Two days later, Trump praised the auto maker, saying it was “doing a fantastic job.” ___ Robert Gillies in Toronto contributed to this report. EMAIL}/redirect EMAIL}/redirect To get Exclusive Offers make sure you grab your cellphone (which you are probably doing right now) and join our VIP text messaging list (standard text and messaging rates may apply)to make it even easier, if you are on your cell phone now click this Button Below: [SIGN ME UP NOW]( © 2019 PTE.la PTE, LLC (publisher of PTE.la) is NOT registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for PTE, LLC may have long or short positions in securities that may be discussed on this website or newsletter. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are simulated figures from virtual simulated portfolios. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. PTE.la’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as are commendation by PTE.la or an offer or solicitation to buy or sell any security. Neither the owner of PTE.la nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with alicensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit . PTE.la makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. PTE.la is owned and operated by PTE LLC. PTE LLC has not been compensated for this specific email, we do have advertisements in this email that we get paid if you click one of the ads (we have not investigated any of the advertisements). Any compensation received by PTE LLC constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. A third party of PTE LLC may have shares and may liquidate, which may negatively affect the stock price. PTE LLC affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market. Some of the content in this release contains forward - looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward - looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company’s filings with the Securities and Exchange Commission. However, acompany’s past performance does not guarantee future results. Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. PTE.la makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. PTE Team 9 Downing street Newark NJ 07105 USA [Unsubscribe]( | [Change Subscriber Options](